We are live on ! Find out more
MM

MWG Management Portfolio holdings

AUM $81.3M
1-Year Est. Return 2.28%
This Fund
S&P 500
This Quarter Est. Return
-30.71%
1 Year Est. Return
+2.28%
3 Year Est. Return
-59.16%
5 Year Est. Return
-10.97%
10 Year Est. Return
AUM
$91.6M
AUM Growth
-$43.5M
Cap. Flow
-$1.96M
Cap. Flow %
-2.15%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
BEAM icon
Beam Therapeutics
BEAM
+$1.96M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEAM icon
1
Beam Therapeutics
BEAM
$2.71B
$53.1M 58.01%
2,266,934
-80,000
-3% -$1.96M
LYEL icon
2
Lyell Immunopharma
LYEL
$317M
$29.2M 31.93%
1,008,117
PRME icon
3
Prime Medicine
PRME
$551M
$9.21M 10.06%
1,792,210

Similar funds

MWG Management's Q2 2024 Portfolio in Review

As of Q2 2024, MWG Management held 3 positions worth $91.6M, down 32% from $135M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 0%. MWG Management opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • MWG Management's biggest Q2 2024 reduction was Beam Therapeutics, cutting an estimated $1.96M.
  • MWG Management's ten largest holdings make up 100% of its $91.6M portfolio in Q2 2024.
  • MWG Management opened 0 new positions and closed 0 in Q2 2024.
  • MWG Management's portfolio value fell 32% quarter-over-quarter to $91.6M.

Based on MWG Management's 13F filing for Q2 2024, filed 13 Aug 2024.